Is it worthy to treat hidradenitis suppurativa with adalimumab in patients with melanoma and other debilitating systemic diseases? A series of clinical dilemmas.
Cathy Yunjia ZhaoPablo Fernandez-PenasPublished in: The Australasian journal of dermatology (2018)